EULAR recommendations for the management of systemic lupus erythematosus: 2023 updateAntonis Fanouriakis, Dimitrios T. Boumpas, Ricard Cervera et al.|Annals of the Rheumatic Diseases|2023Cited by 913
B cell alterations during BAFF inhibition with belimumab in SLEDaniel Ramsköld, Vivianne Malmström, Ioannis Parodis et al.|EBioMedicine|2018Cited by 147
Current Insights on Biomarkers in Lupus Nephritis: A Systematic Review of the LiteratureLeonardo Palazzo, Ioannis Parodis|Journal of Clinical Medicine|2022Cited by 50
Differential molecular signatures in response to CD19-CAR T cell therapy compared with conventional pharmacotherapy in systemic lupus erythematosusPanagiotis Garantziotis, Ioannis Parodis, Lorenzo Beretta et al.|Annals of the Rheumatic Diseases|2025Cited by 16